Determination of the concentration of Teriflunomide in serum and cerebrospinal fluid from patients with multiple sclerosis who are treated with Teriflunomide 14 mg daily.
Phase of Trial: Phase IV
Latest Information Update: 26 Feb 2018
At a glance
- Drugs Teriflunomide (Primary)
- Indications Multiple sclerosis
- Focus Pharmacokinetics
- 26 Feb 2018 New trial record